General Information of the Compound
Compound ID
CP0497329
Compound Name
3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]quinazolin-4-one
    Show/Hide
Structure
Formula
C21H23ClN4O
Molecular Weight
382.895
Canonical SMILES
Clc1cccc(c1)N1CCN(CCCn2cnc3ccccc3c2=O)CC1
    Show/Hide
InChI
InChI=1S/C21H23ClN4O/c22-17-5-3-6-18(15-17)25-13-11-24(12-14-25)9-4-10-26-16-23-20-8-2-1-7-19(20)21(26)27/h1-3,5-8,15-16H,4,9-14H2
    Show/Hide
InChIKey
QRTNQVOGBIPAAV-UHFFFAOYSA-N
Physicochemical Property
logP
3.2622
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
41.37
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45482890
ChEMBL ID
CHEMBL576586
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 234.42 nM
   TI
   LI
   LO
   TS